
Robert A. Wax
Supervisory Patent Examiner (ID: 262, Phone: (571)272-0623 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1805, 1105, 1656, 1506, 1507, 1814, 1652, 1615, 1807, 1653, 1808 |
| Total Applications | 1637 |
| Issued Applications | 935 |
| Pending Applications | 421 |
| Abandoned Applications | 282 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6361199
[patent_doc_number] => 20020058621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-16
[patent_title] => 'Method for induced lactation'
[patent_app_type] => new
[patent_app_number] => 09/910473
[patent_app_country] => US
[patent_app_date] => 2001-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5605
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20020058621.pdf
[firstpage_image] =>[orig_patent_app_number] => 09910473
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/910473 | Method for induced lactation | Jul 19, 2001 | Issued |
Array
(
[id] => 7361640
[patent_doc_number] => 20040014654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Method for treating unstable angina pectoris'
[patent_app_type] => new
[patent_app_number] => 10/333212
[patent_app_country] => US
[patent_app_date] => 2003-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3941
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20040014654.pdf
[firstpage_image] =>[orig_patent_app_number] => 10333212
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/333212 | Method for treating unstable angina pectoris | Jul 19, 2001 | Issued |
Array
(
[id] => 1037556
[patent_doc_number] => 06872705
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-29
[patent_title] => 'Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions'
[patent_app_type] => utility
[patent_app_number] => 09/904753
[patent_app_country] => US
[patent_app_date] => 2001-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5823
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/872/06872705.pdf
[firstpage_image] =>[orig_patent_app_number] => 09904753
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/904753 | Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions | Jul 12, 2001 | Issued |
Array
(
[id] => 5936604
[patent_doc_number] => 20020061852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-23
[patent_title] => 'Methods of therapy with thrombin derived peptides'
[patent_app_type] => new
[patent_app_number] => 09/904090
[patent_app_country] => US
[patent_app_date] => 2001-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5353
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20020061852.pdf
[firstpage_image] =>[orig_patent_app_number] => 09904090
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/904090 | Methods of therapy with thrombin derived peptides | Jul 11, 2001 | Issued |
Array
(
[id] => 1086074
[patent_doc_number] => 06831151
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-12-14
[patent_title] => 'Mast cell-specific signal transducing molecules and cDNAs thereof'
[patent_app_type] => B1
[patent_app_number] => 09/856061
[patent_app_country] => US
[patent_app_date] => 2001-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 6432
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/831/06831151.pdf
[firstpage_image] =>[orig_patent_app_number] => 09856061
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/856061 | Mast cell-specific signal transducing molecules and cDNAs thereof | Jul 9, 2001 | Issued |
| 09/786797 | Human cytoskeleton associated proteins | Jun 24, 2001 | Abandoned |
Array
(
[id] => 7607403
[patent_doc_number] => 07098313
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-29
[patent_title] => 'DNA sequences coding for a polyol carrier and their use, in particular for the preparation of transgenic plants'
[patent_app_type] => utility
[patent_app_number] => 10/332815
[patent_app_country] => US
[patent_app_date] => 2001-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9151
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/098/07098313.pdf
[firstpage_image] =>[orig_patent_app_number] => 10332815
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/332815 | DNA sequences coding for a polyol carrier and their use, in particular for the preparation of transgenic plants | Jun 21, 2001 | Issued |
Array
(
[id] => 6801576
[patent_doc_number] => 20030096741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Enhanced mineral delivery'
[patent_app_type] => new
[patent_app_number] => 09/885593
[patent_app_country] => US
[patent_app_date] => 2001-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4286
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20030096741.pdf
[firstpage_image] =>[orig_patent_app_number] => 09885593
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/885593 | Enhanced mineral delivery | Jun 18, 2001 | Abandoned |
Array
(
[id] => 1080944
[patent_doc_number] => 06835813
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-12-28
[patent_title] => 'Testis-specific differentiation-regulatory factor'
[patent_app_type] => B1
[patent_app_number] => 09/743237
[patent_app_country] => US
[patent_app_date] => 2001-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10080
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/835/06835813.pdf
[firstpage_image] =>[orig_patent_app_number] => 09743237
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/743237 | Testis-specific differentiation-regulatory factor | Jun 3, 2001 | Issued |
Array
(
[id] => 1115463
[patent_doc_number] => 06800492
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-10-05
[patent_title] => 'Chimeric GFP-aequorin as bioluminescent Ca reporters at the single cell level'
[patent_app_type] => B2
[patent_app_number] => 09/863901
[patent_app_country] => US
[patent_app_date] => 2001-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 18
[patent_no_of_words] => 24901
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/800/06800492.pdf
[firstpage_image] =>[orig_patent_app_number] => 09863901
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/863901 | Chimeric GFP-aequorin as bioluminescent Ca reporters at the single cell level | May 23, 2001 | Issued |
| 09/763919 | Pharmaceutical compositions comprising factor xillla | May 20, 2001 | Abandoned |
Array
(
[id] => 6559497
[patent_doc_number] => 20020164640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'MyD88 adapter-like proteins'
[patent_app_type] => new
[patent_app_number] => 09/860696
[patent_app_country] => US
[patent_app_date] => 2001-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15602
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20020164640.pdf
[firstpage_image] =>[orig_patent_app_number] => 09860696
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/860696 | MyD88 adapter-like proteins | May 16, 2001 | Issued |
| 09/701787 | Peptides having nuclear transport activity | May 10, 2001 | Abandoned |
Array
(
[id] => 6638958
[patent_doc_number] => 20030211993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Method for promoting neovascularization'
[patent_app_type] => new
[patent_app_number] => 10/275997
[patent_app_country] => US
[patent_app_date] => 2002-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10877
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20030211993.pdf
[firstpage_image] =>[orig_patent_app_number] => 10275997
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/275997 | Method for promoting neovascularization | May 6, 2001 | Issued |
Array
(
[id] => 1024736
[patent_doc_number] => 06884778
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-04-26
[patent_title] => 'Biocompatible macromers'
[patent_app_type] => utility
[patent_app_number] => 09/845570
[patent_app_country] => US
[patent_app_date] => 2001-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8877
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/884/06884778.pdf
[firstpage_image] =>[orig_patent_app_number] => 09845570
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/845570 | Biocompatible macromers | Apr 29, 2001 | Issued |
Array
(
[id] => 6406185
[patent_doc_number] => 20020182668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-05
[patent_title] => 'Human PEG3 gene and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/842777
[patent_app_country] => US
[patent_app_date] => 2001-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8154
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20020182668.pdf
[firstpage_image] =>[orig_patent_app_number] => 09842777
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/842777 | Human PEG3 gene and uses thereof | Apr 26, 2001 | Abandoned |
| 09/830244 | LYSINE-RICH STATHERIN PROTEIN | Apr 22, 2001 | Abandoned |
Array
(
[id] => 985627
[patent_doc_number] => 06924357
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-02
[patent_title] => 'Lipid binding protein 4'
[patent_app_type] => utility
[patent_app_number] => 10/257637
[patent_app_country] => US
[patent_app_date] => 2001-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9739
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/924/06924357.pdf
[firstpage_image] =>[orig_patent_app_number] => 10257637
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/257637 | Lipid binding protein 4 | Apr 10, 2001 | Issued |
Array
(
[id] => 6792713
[patent_doc_number] => 20030088057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'PEPTIDE SUBSTRATES PHOSPHORYLATED BY P21-ACTIVAGED PROTEIN KINASE STATEMENT REGARDING FEDERALLY SPONSORED REASEARCH OR DEVELOPMENT'
[patent_app_type] => new
[patent_app_number] => 09/827542
[patent_app_country] => US
[patent_app_date] => 2001-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8720
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20030088057.pdf
[firstpage_image] =>[orig_patent_app_number] => 09827542
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/827542 | PEPTIDE SUBSTRATES PHOSPHORYLATED BY P21-ACTIVAGED PROTEIN KINASE STATEMENT REGARDING FEDERALLY SPONSORED REASEARCH OR DEVELOPMENT | Apr 5, 2001 | Abandoned |
Array
(
[id] => 6683127
[patent_doc_number] => 20030118991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Ataxia-telangiectasia gene and its genomic organization'
[patent_app_type] => new
[patent_app_number] => 09/825476
[patent_app_country] => US
[patent_app_date] => 2001-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22652
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20030118991.pdf
[firstpage_image] =>[orig_patent_app_number] => 09825476
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/825476 | Ataxia-telangiectasia gene and its genomic organization | Apr 2, 2001 | Abandoned |